Mesa Laboratories Inc (MLAB)

$107.69

+1.66

(+1.57%)

Market is closed - opens 8 PM, 28 Feb 2024

Insights on Mesa Laboratories Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 50.64M → 53.47M (in $), with an average increase of 2.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -1.23M → 2.11M (in $), with an average increase of 158.1% per quarter

  • Vs GRMN

    In the last 1 year, Garmin Ltd. has given 37.3% return, outperforming this stock by 76.3%

  • Vs FTV

    In the last 3 years, Fortive Corp has given 8.6% return, outperforming this stock by 69.0%

Performance

  • $105.68
    $109.98
    $107.69
    downward going graph

    1.87%

    Downside

    Day's Volatility :3.91%

    Upside

    2.09%

    downward going graph
  • $82.56
    $186.21
    $107.69
    downward going graph

    23.34%

    Downside

    52 Weeks Volatility :55.66%

    Upside

    42.17%

    downward going graph

Returns

PeriodMesa Laboratories IncSector (Health Care)Index (Russel 2000)
3 Months
22.95%
13.2%
0.0%
6 Months
-22.94%
9.7%
0.0%
1 Year
-38.96%
15.4%
-6.7%
3 Years
-61.32%
30.3%
-19.6%

Highlights

Market Capitalization
571.9M
Book Value
$74.71
Dividend Share
0.64
Dividend Yield
0.6%
Earnings Per Share (EPS)
0.17
PE Ratio
623.71
PEG Ratio
0.0
Wall Street Target Price
127.0
Profit Margin
0.45%
Operating Margin TTM
2.09%
Return On Assets TTM
0.13%
Return On Equity TTM
0.24%
Revenue TTM
212.9M
Revenue Per Share TTM
39.6
Quarterly Revenue Growth YOY
-1.5%
Gross Profit TTM
116.6M
EBITDA
35.7M
Diluted Eps TTM
0.17
Quarterly Earnings Growth YOY
3.88
EPS Estimate Current Year
-0.08
EPS Estimate Next Year
0.62
EPS Estimate Current Quarter
0.19
EPS Estimate Next Quarter
0.35

Analyst Recommendation

Buy
    66%Buy
    33%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Mesa Laboratories Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 17.93%

Current $107.69
Target $127.00

Company Financials

FY18Y/Y Change
Revenue
96.2M
↑ 2.68%
Net Income
-3.0M
↓ 126.49%
Net Profit Margin
-3.08%
↓ 15.02%
FY19Y/Y Change
Revenue
103.1M
↑ 7.23%
Net Income
7.5M
↓ 352.67%
Net Profit Margin
7.26%
↑ 10.34%
FY20Y/Y Change
Revenue
117.7M
↑ 14.11%
Net Income
1.3M
↓ 81.97%
Net Profit Margin
1.15%
↓ 6.11%
FY21Y/Y Change
Revenue
133.9M
↑ 13.81%
Net Income
3.3M
↑ 142.7%
Net Profit Margin
2.44%
↑ 1.29%
FY22Y/Y Change
Revenue
184.3M
↑ 37.63%
Net Income
1.9M
↓ 42.85%
Net Profit Margin
1.01%
↓ 1.43%
FY23Y/Y Change
Revenue
219.1M
↑ 18.85%
Net Income
930.0K
↓ 50.29%
Net Profit Margin
0.42%
↓ 0.59%
Q3 FY22Q/Q Change
Revenue
58.7M
↑ 16.44%
Net Income
1.3M
↓ 190.82%
Net Profit Margin
2.22%
↑ 5.07%
Q4 FY22Q/Q Change
Revenue
54.3M
↓ 7.6%
Net Income
451.0K
↓ 65.47%
Net Profit Margin
0.83%
↓ 1.39%
Q1 FY23Q/Q Change
Revenue
55.6M
↑ 2.4%
Net Income
611.0K
↑ 35.48%
Net Profit Margin
1.1%
↑ 0.27%
Q2 FY23Q/Q Change
Revenue
50.6M
↓ 8.9%
Net Income
-549.0K
↓ 189.85%
Net Profit Margin
-1.08%
↓ 2.18%
Q3 FY23Q/Q Change
Revenue
53.2M
↑ 4.98%
Net Income
-1.2M
↑ 124.04%
Net Profit Margin
-2.31%
↓ 1.23%
Q4 FY23Q/Q Change
Revenue
53.5M
↑ 0.58%
Net Income
2.1M
↓ 272.03%
Net Profit Margin
3.96%
↑ 6.27%
FY18Y/Y Change
Total Assets
164.1M
↓ 4.44%
Total Liabilities
64.7M
↓ 12.41%
FY19Y/Y Change
Total Assets
156.8M
↓ 4.47%
Total Liabilities
45.5M
↓ 29.79%
FY20Y/Y Change
Total Assets
420.2M
↑ 168.04%
Total Liabilities
200.2M
↑ 340.41%
FY21Y/Y Change
Total Assets
600.2M
↑ 42.82%
Total Liabilities
193.9M
↓ 3.13%
FY22Y/Y Change
Total Assets
707.4M
↑ 17.87%
Total Liabilities
313.6M
↑ 61.7%
FY23Y/Y Change
Total Assets
661.8M
↓ 6.44%
Total Liabilities
268.4M
↓ 14.42%
Q3 FY22Q/Q Change
Total Assets
656.2M
↓ 4.31%
Total Liabilities
282.0M
↓ 7.66%
Q4 FY22Q/Q Change
Total Assets
663.0M
↑ 1.03%
Total Liabilities
275.8M
↓ 2.2%
Q1 FY23Q/Q Change
Total Assets
661.8M
↓ 0.17%
Total Liabilities
268.4M
↓ 2.69%
Q2 FY23Q/Q Change
Total Assets
642.6M
↓ 2.9%
Total Liabilities
254.9M
↓ 5.02%
Q3 FY23Q/Q Change
Total Assets
637.2M
↓ 0.84%
Total Liabilities
249.4M
↓ 2.14%
Q4 FY23Q/Q Change
Total Assets
741.8M
↑ 16.41%
Total Liabilities
338.8M
↑ 35.83%
FY18Y/Y Change
Operating Cash Flow
24.8M
↑ 220.18%
Investing Cash Flow
-17.2M
↓ 6.63%
Financing Cash Flow
-8.1M
↓ 175.82%
FY19Y/Y Change
Operating Cash Flow
30.6M
↑ 23.13%
Investing Cash Flow
-3.9M
↓ 77.42%
Financing Cash Flow
-21.7M
↑ 166.93%
FY20Y/Y Change
Operating Cash Flow
26.6M
↓ 13.08%
Investing Cash Flow
-185.6M
↑ 4683.12%
Financing Cash Flow
231.3M
↓ 1167.17%
FY21Y/Y Change
Operating Cash Flow
37.1M
↑ 39.59%
Investing Cash Flow
-2.0M
↓ 98.93%
Financing Cash Flow
146.2M
↓ 36.77%
FY22Y/Y Change
Operating Cash Flow
39.2M
↑ 5.8%
Investing Cash Flow
-305.2M
↑ 15222.54%
Financing Cash Flow
52.6M
↓ 64.05%
FY23Y/Y Change
Operating Cash Flow
28.0M
↓ 28.66%
Investing Cash Flow
-9.5M
↓ 96.89%
Financing Cash Flow
-33.3M
↓ 163.39%
Q3 FY22Q/Q Change
Operating Cash Flow
10.6M
↓ 475.56%
Investing Cash Flow
-1.6M
↑ 628.44%
Financing Cash Flow
-18.6M
↑ 1225.23%
Q4 FY22Q/Q Change
Operating Cash Flow
7.7M
↓ 26.89%
Investing Cash Flow
-6.6M
↑ 302.93%
Financing Cash Flow
-8.9M
↓ 52.36%
Q1 FY23Q/Q Change
Operating Cash Flow
12.5M
↑ 62.21%
Investing Cash Flow
-1.0M
↓ 84.46%
Financing Cash Flow
-4.4M
↓ 50.56%
Q2 FY23Q/Q Change
Operating Cash Flow
9.9M
↓ 20.61%
Investing Cash Flow
-270.0K
↓ 73.68%
Financing Cash Flow
-9.5M
↑ 116.73%

Technicals Summary

Sell

Neutral

Buy

Mesa Laboratories Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mesa Laboratories Inc
Mesa Laboratories Inc
11.73%
-22.94%
-38.96%
-61.32%
-53.17%
Teledyne Technologies Inc
Teledyne Technologies Inc
-0.99%
2.11%
-1.2%
11.73%
80.01%
Trimble Navigation Limited
Trimble Navigation Limited
19.78%
16.0%
18.67%
-20.35%
54.41%
Fortive Corp
Fortive Corp
15.3%
11.11%
29.19%
26.68%
26.17%
Garmin Ltd.
Garmin Ltd.
7.59%
28.67%
37.26%
5.01%
60.4%
Keysight Technologies, Inc.
Keysight Technologies, Inc.
-4.12%
18.18%
-4.5%
5.75%
80.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mesa Laboratories Inc
Mesa Laboratories Inc
623.71
623.71
0.0
-0.08
0.0
0.0
0.01
74.71
Teledyne Technologies Inc
Teledyne Technologies Inc
23.06
23.06
0.98
20.56
0.1
0.05
NA
194.82
Trimble Navigation Limited
Trimble Navigation Limited
49.45
49.45
2.27
2.71
0.07
0.04
NA
18.16
Fortive Corp
Fortive Corp
35.23
35.23
1.45
3.79
0.09
0.04
0.0
29.42
Garmin Ltd.
Garmin Ltd.
20.15
20.15
3.56
5.46
0.2
0.08
0.02
36.56
Keysight Technologies, Inc.
Keysight Technologies, Inc.
27.92
27.92
2.8
6.26
0.21
0.09
NA
27.54
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mesa Laboratories Inc
Mesa Laboratories Inc
Buy
$571.9M
-53.17%
623.71
0.45%
Teledyne Technologies Inc
Teledyne Technologies Inc
Buy
$20.1B
80.01%
23.06
15.72%
Trimble Navigation Limited
Trimble Navigation Limited
Buy
$15.4B
54.41%
49.45
8.19%
Fortive Corp
Fortive Corp
Buy
$30.0B
26.17%
35.23
14.28%
Garmin Ltd.
Garmin Ltd.
Buy
$25.9B
60.4%
20.15
24.67%
Keysight Technologies, Inc.
Keysight Technologies, Inc.
Buy
$26.5B
80.97%
27.92
18.14%

Institutional Holdings

  • BlackRock Inc

    14.94%
  • Conestoga Capital Advisors, LLC

    10.72%
  • Vanguard Group Inc

    6.73%
  • Royce & Associates, LP

    5.00%
  • Morgan Stanley - Brokerage Accounts

    4.51%
  • Ranger Investment Management LP

    4.20%

Corporate Announcements

  • Mesa Laboratories Inc Dividends March,2024

    In the quarter ending March,2024. Mesa Laboratories Inc has declared dividend of $0.16

    Read More

Company Information

mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers

Organization
Mesa Laboratories Inc
Employees
698
CEO
Mr. Gary M. Owens
Industry
Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

FAQs